Middle East and Africa Neurovascular Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product ; Application ; End User and Country

Middle East and Africa Neurovascular Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product ; Application ; End User and Country

  • November 2020 •
  • 98 pages •
  • Report ID: 5999736 •
  • Format: PDF
Market Introduction
Neurovascular devices are used to treat neurovascular diseases that possibly affect the network of blood vessels that surround the brain.Neurovascular disorders lead to incurable conditions such as strokes and aneurysms.

Neurovascular devices are used to prevent stroke, aneurysm embolization, carotid stenosis, and other symptoms. Neurovascular devices are also used for performing surgical procedures to treat aneurysms and other cranial blood flow problems.

Market Overview and Dynamics
The Middle East and Africa neurovascular devices market is expected to reach US$ 144.08 Mn in 2027 from US$ 119.85 Mn in 2019. The market is estimated to grow with a CAGR of 2.4% from 2020-2027. Key factors that are driving growth of Middle East and Africa Neurovascular Devices market are Increasing Incidences of neurovascular diseases, rising demand for minimally invasive procedures, and significantly growing aging population. However, the market is expected to grow at slower pace owing to the factors such as high cost of embolization coils and lack of expert professionals operating neurovascular disorders.

Key Market Segments
The Middle East and Africa neurovascular devices market, based on the product was segmented into neurothrombectomy devices, aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems and support devices. The aneurysm coiling & embolization devices held the largest share of the market in 2019, and is anticipated to register the highest CAGR in the market during the forecast period.
The Middle East and Africa neurovascular devices market, based on the application was segmented into cerebral aneurysms, ischemic strokes, arteriovenous malformation & fistulas, and other applications. In 2019, ischemic strokes segment held the largest share of the market and is expected to register the highest CAGR in the market during the forecast period.
Based on end user, the Middle East and Africa neurovascular devices market, was segmented into hospitals, ambulatory surgical centers and specialized clinics. In 2019, hospitals segment held the largest share of the market and is registered to dominate the market at the highest CAGR during the forecast period.

Major Sources and Companies Listed
Some of the major primary and secondary sources for Middle East and Africa neurovascular devices market included in the report are Neurology Association of South Africa (NASA); World Bank; World Stroke Organisation (WSO); and World Health Organisation (WHO); among others.

Middle East and Africa North America Neurovascular Devices market –
By Product
• Neurothrombectomy Devices
o Clot Retrieval Devices
o Suction & Aspiration Devices
o Snares
• Aneurysm Coiling & Embolization Devices
o Embolic Coils
Bare Detachable Coils
Coated Detachable Coils
o Flow Diversion Devices
o Liquid Embolic Agents
• Cerebral Balloon Angioplasty & Stenting Systems
o Carotid Artery Stents
o Embolic Protection Systems
Balloon Occlusion Devices
Distal Fillers
• Support Devices
o Microcatheters
o Microguidewires
By Application
• Cerebral Aneurysms
• Arteriovenous Malformation & Fistulas
• Other Applications
By End User
• Hospitals
• Ambulatory Surgical Centers
• Specialized Clinics
By Country
o UAE
o Saudi Arabia
o South Africa
o Rest of Middle East and Africa

Company Profiles

• Medtronic plc
• Johnson and Johnson, Inc (DePuy Synthes)
• Penumbra, Inc
• Terumo Corporation
• Acandis GmbH & Co. KG
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.